Single cell-resolution in situ sequencing elucidates spatial dynamics of multiple sclerosis lesion and disease evolution

Multiple sclerosis (MS) is a neurological disease characterised by multifocal lesions and smouldering pathology. While single-cell analyses have provided insights into neuropathology, cellular processes underlying MS remain poorly understood. We modelled the cellular dynamics of MS by examining temporal and regional rates of disease progression in the experimental autoimmune encephalomyelitis (EAE) mouse model. By performing single-cell spatial expression profiling using In situ sequencing, we annotated disease neighbourhoods during lesion evolution and found centrifugal propagation of active lesions. We demonstrated that disease-associated (DA) glia are dynamic and induced independently of lesions, preceding their formation. Single-cell spatial analysis of human archival MS spinal cord confirmed differential distribution of DA-glia, enabled deconvolution of active and inactive lesions into sub-compartments, and identification of new lesion areas. By establishing a spatial resource of mouse and human MS neuropathology at a single-cell resolution, our study unveils the intricate cellular dynamics underlying MS disease evolution.

[1]  Alexander R. Pico,et al.  Defining blood-induced microglia functions in neurodegeneration through multiomic profiling , 2023, Nature Immunology.

[2]  D. Gosselin,et al.  Roles and regulation of microglia activity in multiple sclerosis: insights from animal models , 2023, Nature Reviews Neuroscience.

[3]  L. Alfredsson,et al.  Cross-reactive EBNA1 immunity targets alpha-crystallin B and is associated with multiple sclerosis , 2023, Science advances.

[4]  T. Kuhlmann,et al.  Inflammation in multiple sclerosis: consequences for remyelination and disease progression , 2023, Nature Reviews Neurology.

[5]  M. Kerschensteiner,et al.  Remyelination by surviving oligodendrocytes is inefficient in the inflamed mammalian cortex , 2023, Neuron.

[6]  Hanseul Park,et al.  Single-cell RNA-sequencing identifies disease-associated oligodendrocytes in male APP NL-G-F and 5XFAD mice , 2023, Nature Communications.

[7]  Christopher J. Bohlen,et al.  Integrative in situ mapping of single-cell transcriptional states and tissue histopathology in a mouse model of Alzheimer’s disease , 2023, Nature Neuroscience.

[8]  L. Steinman,et al.  Experimental encephalomyelitis at age 90, still relevant and elucidating how viruses trigger disease , 2023, The Journal of experimental medicine.

[9]  B. McColl,et al.  Microglia regulate central nervous system myelin growth and integrity , 2022, Nature.

[10]  J. Ragoussis,et al.  Single-Cell Transcriptomics Identifies Brain Endothelium Inflammatory Networks in Experimental Autoimmune Encephalomyelitis , 2022, Neurology: Neuroimmunology & Neuroinflammation.

[11]  Miguel A. Ibarra-Arellano,et al.  Spatial cell type mapping of multiple sclerosis lesions , 2022, bioRxiv.

[12]  M. Simons,et al.  CD8+ T cells induce interferon-responsive oligodendrocytes and microglia in white matter aging , 2022, Nature Neuroscience.

[13]  Trygve E Bakken,et al.  Transcriptomic diversity of cell types across the adult human brain , 2022, bioRxiv.

[14]  J. Saez-Rodriguez,et al.  Cross-regional homeostatic and reactive glial signatures in multiple sclerosis , 2022, Acta Neuropathologica.

[15]  Sergio Marco Salas,et al.  Harmonized single-cell landscape, intercellular crosstalk and tumor architecture of glioblastoma , 2022, bioRxiv.

[16]  M. Plikus,et al.  Screening cell–cell communication in spatial transcriptomics via collective optimal transport , 2022, bioRxiv.

[17]  Tracy J. Yuen,et al.  Disease-associated oligodendrocyte responses across neurodegenerative diseases. , 2022, Cell reports.

[18]  I. Amit,et al.  A shared disease-associated oligodendrocyte signature among multiple CNS pathologies , 2022, Nature Neuroscience.

[19]  Peng Tan,et al.  Spatial Atlas of the Mouse Central Nervous System at Molecular Resolution , 2022, bioRxiv.

[20]  José Fernández Navarro,et al.  Identification of early neurodegenerative pathways in progressive multiple sclerosis , 2022, Nature Neuroscience.

[21]  R. Adams,et al.  Single-cell transcriptomics reveals functionally specialized vascular endothelium in brain , 2022, bioRxiv.

[22]  D. Perl,et al.  Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation , 2022, Cell.

[23]  Markus M. Hilscher,et al.  Spatial and temporal heterogeneity in the lineage progression of fine oligodendrocyte subtypes , 2022, BMC Biology.

[24]  Mats F. Nilsson,et al.  Direct RNA targeted in situ sequencing for transcriptomic profiling in tissue , 2022, Scientific Reports.

[25]  O. Elemento,et al.  Unsupervised discovery of tissue architecture in multiplexed imaging , 2022, bioRxiv.

[26]  Fabian J Theis,et al.  Spatial components of molecular tissue biology , 2022, Nature Biotechnology.

[27]  Erik L. G. Wernersson,et al.  Deconwolf enables high-performance deconvolution of widefield fluorescence microscopy images , 2022 .

[28]  Thomas E. Nichols,et al.  How patients with multiple sclerosis acquire disability , 2022, Brain : a journal of neurology.

[29]  Fabian J Theis,et al.  Squidpy: a scalable framework for spatial omics analysis , 2022, Nature Methods.

[30]  Mark S. Anderson,et al.  Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM , 2022, Nature.

[31]  S. Elledge,et al.  Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis , 2022, Science.

[32]  M. Gerstung,et al.  Cell2location maps fine-grained cell types in spatial transcriptomics , 2022, Nature Biotechnology.

[33]  C. Granziera,et al.  Smouldering multiple sclerosis: the ‘real MS’ , 2022, Therapeutic advances in neurological disorders.

[34]  V. Yong,et al.  Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis , 2021, Nature Reviews Neurology.

[35]  Evan Z. Macosko,et al.  Deep learning and alignment of spatially resolved single-cell transcriptomes with Tangram , 2021, Nature Methods.

[36]  W. Richardson,et al.  G protein‐coupled receptor GPR37‐like 1 regulates adult oligodendrocyte generation , 2021, Developmental neurobiology.

[37]  Ariel J. Levine,et al.  A harmonized atlas of mouse spinal cord cell types and their spatial organization , 2021, Nature Communications.

[38]  D. Reich,et al.  A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis , 2021, Nature.

[39]  N. Friedman,et al.  NovoSpaRc: flexible spatial reconstruction of single-cell gene expression with optimal transport , 2021, Nature Protocols.

[40]  J. Kira Redefining use of MRI for patients with multiple sclerosis , 2021, The Lancet Neurology.

[41]  M. Duddy,et al.  COVID-19 is associated with new symptoms of multiple sclerosis that are prevented by disease modifying therapies , 2021, Multiple Sclerosis and Related Disorders.

[42]  Jeremy L. Muhlich,et al.  Stitching and registering highly multiplexed whole-slide images of tissues and tumors using ASHLAR , 2021, bioRxiv.

[43]  J. Shu,et al.  ClusterMap: multi-scale clustering analysis of spatial gene expression , 2021, bioRxiv.

[44]  Kira E. Poskanzer,et al.  Reactive astrocyte nomenclature, definitions, and future directions , 2021, Nature Neuroscience.

[45]  R. Franklin,et al.  Schwann cell remyelination of the central nervous system: why does it happen and what are the benefits? , 2021, Open Biology.

[46]  Markus M. Hilscher,et al.  Distinct oligodendrocyte populations have spatial preference and different responses to spinal cord injury , 2020, Nature Communications.

[47]  O. Harismendy,et al.  Deciphering cell–cell interactions and communication from gene expression , 2020, Nature reviews. Genetics.

[48]  Raphael Gottardo,et al.  Integrated analysis of multimodal single-cell data , 2020, Cell.

[49]  Joseph Bergenstråhle,et al.  Single-cell and spatial transcriptomics enables probabilistic inference of cell type topography , 2020, Communications Biology.

[50]  Sergio Marco Salas,et al.  Hybridization-based in situ sequencing (HybISS) for spatially resolved transcriptomics in human and mouse brain tissue , 2020, Nucleic acids research.

[51]  Trygve E Bakken,et al.  NS-Forest: A machine learning method for the objective identification of minimum marker gene combinations for cell type determination from single cell RNA sequencing , 2020, bioRxiv.

[52]  K. Kuter,et al.  Overview of General and Discriminating Markers of Differential Microglia Phenotypes , 2020, Frontiers in Cellular Neuroscience.

[53]  Lihua Zhang,et al.  Inference and analysis of cell-cell communication using CellChat , 2020, Nature Communications.

[54]  Anna C. Williams,et al.  New oligodendrocytes exhibit more abundant and accurate myelin regeneration than those that survive demyelination , 2020, Nature Neuroscience.

[55]  O. Lindvall,et al.  Pericyte-derived fibrotic scarring is conserved across diverse central nervous system lesions , 2020, Nature Communications.

[56]  J. Ragoussis,et al.  MAFG-driven astrocytes promote CNS inflammation , 2020, Nature.

[57]  Christopher C. Overall,et al.  The active contribution of OPCs to neuroinflammation is mediated by LRP1 , 2019, Acta Neuropathologica.

[58]  C. Welle,et al.  Motor Learning Promotes Remyelination via New and Surviving Oligodendrocytes , 2020, Nature Neuroscience.

[59]  D. Holtzman,et al.  Human and mouse single-nucleus transcriptomics reveal TREM2-dependent and TREM2-independent cellular responses in Alzheimer’s disease , 2020, Nature Medicine.

[60]  Yumeng Zhang,et al.  Characterization of a long noncoding RNA Pcdh17it as a novel marker for immature premyelinating oligodendrocytes , 2019, Glia.

[61]  K. Harris,et al.  Probabilistic cell typing enables fine mapping of closely related cell types in situ , 2019, Nature Methods.

[62]  D. Reich,et al.  Potential role of iron in repair of inflammatory demyelinating lesions. , 2019, The Journal of clinical investigation.

[63]  Kyle A. Martin,et al.  Oligodendrocyte precursor cells present antigen and are cytotoxic targets in inflammatory demyelination , 2019, Nature Communications.

[64]  P. Nilsson,et al.  Molecular mimicry between Anoctamin 2 and Epstein-Barr virus nuclear antigen 1 associates with multiple sclerosis risk , 2019, Proceedings of the National Academy of Sciences.

[65]  Reiji Yamazaki,et al.  Tracking the evolution of CNS remyelinating lesion in mice with neutral red dye , 2019, Proceedings of the National Academy of Sciences.

[66]  O. Ciccarelli,et al.  Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines , 2019, Brain : a journal of neurology.

[67]  Richard Reynolds,et al.  Neuronal vulnerability and multilineage diversity in multiple sclerosis , 2019, Nature.

[68]  J. Dunn,et al.  Central nervous system targeted autoimmunity causes regional atrophy: a 9.4T MRI study of the EAE mouse model of Multiple Sclerosis , 2019, Scientific Reports.

[69]  Fabian J Theis,et al.  PAGA: graph abstraction reconciles clustering with trajectory inference through a topology preserving map of single cells , 2019, Genome biology.

[70]  Sagar,et al.  Spatial and temporal heterogeneity of mouse and human microglia at single-cell resolution , 2019, Nature.

[71]  O. Ciccarelli,et al.  Spatial distribution of multiple sclerosis lesions in the cervical spinal cord , 2019, Brain : a journal of neurology.

[72]  Tuan Leng Tay,et al.  Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation , 2019, Science.

[73]  D. Malhotra,et al.  Altered human oligodendrocyte heterogeneity in multiple sclerosis , 2019, Nature.

[74]  S. Bernard,et al.  Dynamics of oligodendrocyte generation in multiple sclerosis , 2019, Nature.

[75]  Hongkui Zeng,et al.  Multimodal cell type correspondence by intersectional mFISH in intact tissues , 2019, bioRxiv.

[76]  H. Lassmann Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis , 2019, Front. Immunol..

[77]  Sueli Marques,et al.  Disease-specific oligodendrocyte lineage cells arise in multiple sclerosis , 2018, Nature Medicine.

[78]  Vincent A. Traag,et al.  From Louvain to Leiden: guaranteeing well-connected communities , 2018, Scientific Reports.

[79]  Åsa K. Björklund,et al.  Transcriptional Convergence of Oligodendrocyte Lineage Progenitors during Development , 2018, Developmental cell.

[80]  Ole Kiehn,et al.  Neuronal atlas of the dorsal horn defines its architecture and links sensory input to transcriptional cell types , 2018, Nature Neuroscience.

[81]  Lars E. Borm,et al.  Molecular Architecture of the Mouse Nervous System , 2018, Cell.

[82]  H. Lassmann Multiple Sclerosis Pathology. , 2018, Cold Spring Harbor perspectives in medicine.

[83]  Li Li,et al.  Massively Parallel Single Nucleus Transcriptional Profiling Defines Spinal Cord Neurons and Their Activity during Behavior , 2018, Cell reports.

[84]  C. V. van Eden,et al.  Progressive multiple sclerosis patients show substantial lesion activity that correlates with clinical disease severity and sex: a retrospective autopsy cohort analysis , 2018, Acta Neuropathologica.

[85]  Fabian J Theis,et al.  SCANPY: large-scale single-cell gene expression data analysis , 2018, Genome Biology.

[86]  Loic A. Royer,et al.  Content-aware image restoration: pushing the limits of fluorescence microscopy , 2018, bioRxiv.

[87]  P. Morgan,et al.  Imaging central veins in brain lesions with 3-T T2*-weighted magnetic resonance imaging differentiates multiple sclerosis from microangiopathic brain lesions , 2016, Multiple sclerosis.

[88]  Massimo Filippi,et al.  Persistent 7-tesla phase rim predicts poor outcome in new multiple sclerosis patient lesions. , 2016, The Journal of clinical investigation.

[89]  Jens Hjerling-Leffler,et al.  Oligodendrocyte heterogeneity in the mouse juvenile and adult central nervous system , 2016, Science.

[90]  E. Peles,et al.  G protein-coupled receptor 37 is a negative regulator of oligodendrocyte differentiation and myelination , 2016, Nature Communications.

[91]  Camille J. Olechowski,et al.  Granzyme B-inhibitor serpina3n induces neuroprotection in vitro and in vivo , 2015, Journal of Neuroinflammation.

[92]  A. Regev,et al.  Spatial reconstruction of single-cell gene expression data , 2015 .

[93]  S. Linnarsson,et al.  Cell types in the mouse cortex and hippocampus revealed by single-cell RNA-seq , 2015, Science.

[94]  F. Jacques Defining the clinical course of multiple sclerosis: The 2013 revisions , 2015, Neurology.

[95]  Jeffrey A. Cohen,et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions. , 2014, Neurology.

[96]  T. Pozzan,et al.  Tumor necrosis factor-α impairs oligodendroglial differentiation through a mitochondria-dependent process , 2014, Cell Death and Differentiation.

[97]  D. Holmberg,et al.  Global and 3D Spatial Assessment of Neuroinflammation in Rodent Models of Multiple Sclerosis , 2013, PloS one.

[98]  Carolina Wählby,et al.  In situ sequencing for RNA analysis in preserved tissue and cells , 2013, Nature Methods.

[99]  Michelle M. Giddens,et al.  GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin , 2013, Proceedings of the National Academy of Sciences.

[100]  J. Goverman,et al.  Mechanisms regulating regional localization of inflammation during CNS autoimmunity , 2012, Immunological reviews.

[101]  Steven M LeVine,et al.  Pathogenic implications of iron accumulation in multiple sclerosis , 2012, Journal of neurochemistry.

[102]  B. Scheithauer,et al.  Inflammatory cortical demyelination in early multiple sclerosis. , 2011, The New England journal of medicine.

[103]  A. Pachner Experimental models of multiple sclerosis. , 2011, Current opinion in neurology.

[104]  Xiaoyu Xia,et al.  An Animal Model of Cortical and Callosal Pathology in Multiple Sclerosis , 2011, Brain pathology.

[105]  Jullie W Pan,et al.  DEMONSTRATING THE PERIVASCULAR DISTRIBUTION OF MS LESIONS IN VIVO WITH 7-TESLA MRI , 2008, Neurology.

[106]  P. Sawchenko,et al.  Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the pathogenesis of experimental autoimmune encephalomyelitis , 2007, The Journal of comparative neurology.

[107]  Lisa K. Peterson,et al.  Inflammation, demyelination, neurodegeneration and neuroprotection in the pathogenesis of multiple sclerosis , 2007, Journal of Neuroimmunology.

[108]  S. Miller,et al.  Interferon-γ-Oligodendrocyte Interactions in the Regulation of Experimental Autoimmune Encephalomyelitis , 2007, The Journal of Neuroscience.

[109]  T. Speed,et al.  Functional Genomic Analysis of Oligodendrocyte Differentiation , 2006, The Journal of Neuroscience.

[110]  J. Ting,et al.  TNFα promotes proliferation of oligodendrocyte progenitors and remyelination , 2001, Nature Neuroscience.

[111]  C. D. DE GROOT,et al.  Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS , 2000, Neuropathology and applied neurobiology.

[112]  H. Lassmann,et al.  Autoimmunity to Myelin Oligodendrocyte Glycoprotein in Rats Mimics the Spectrum of Multiple Sclerosis Pathology , 1998, Brain pathology.

[113]  F. Dudek,et al.  Grid‐mapped freeze‐fracture analysis of gap junctions in gray and white matter of adult rat central nervous system, with evidence for a “panglial syncytium” that is not coupled to neurons , 1997, The Journal of comparative neurology.

[114]  A. Thompson,et al.  Spinal MRI in patients with suspected multiple sclerosis and negative brain MRI. , 1996, Brain : a journal of neurology.

[115]  A. Ben-nun,et al.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.

[116]  T. Olsson,et al.  Autoreactive T lymphocytes in multiple sclerosis determined by antigen-induced secretion of interferon-gamma. , 1990, The Journal of clinical investigation.

[117]  Alejandro F. Frangi,et al.  Medical Image Computing and Computer Assisted Intervention – MICCAI 2018 , 2018, Lecture Notes in Computer Science.

[118]  T. Olsson,et al.  Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis , 2017, Nature Reviews Neurology.

[119]  Hans Lassmann,et al.  An updated histological classification system for multiple sclerosis lesions , 2016, Acta Neuropathologica.

[120]  F. Quintana,et al.  [Immunopathology of multiple sclerosis]. , 2014, Medicina.

[121]  U. Bogdahn,et al.  Experimental autoimmune encephalomyelitis in the rat spinal cord: lesion detection with high-resolution MR microscopy at 17.6 T. , 2005, AJNR. American journal of neuroradiology.